Literature DB >> 15365001

Identification of the emerging pathogen Vibrio vulnificus biotype 3 by commercially available phenotypic methods.

Raul Colodner1, Raul Raz, Irit Meir, Tsilia Lazarovich, Larisa Lerner, June Kopelowitz, Yoram Keness, Waheeb Sakran, Shifra Ken-Dror, Naiel Bisharat.   

Abstract

Identification of the emerging pathogen Vibrio vulnificus biotype 3 has become a challenge for clinical laboratories in the last few years. In this study, the abilities of five commercial systems to identify this new species have been evaluated for the first time, using a unique collection of strains. Fifty-one well-documented wild strains of V. vulnificus biotype 3 were processed using API 20 NE, GNI+ Vitek 1 cards, ID-GNB Vitek 2 cards, Neg Combo 20 Microscan panels, and NMIC/ID-5 BD Phoenix panels. The numbers of strains identified as V. vulnificus by ID-GNB, NMIC/ID-5, and GNI+ were 50 (98.0%), 46 (90.2%), and 7 (13.7%), respectively. Neg Combo 20 Microscan panels and API 20 NE were unable to identify any of the strains of this emerging pathogen to the species level and mostly misidentifies them as other species of the Vibrionaceae family. Data on the phenotypic pattern of V. vulnificus biotype 3 when processed in all five systems as presented here could help clinical laboratories in identifying this new pathogen.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15365001      PMCID: PMC516291          DOI: 10.1128/JCM.42.9.4137-4140.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  9 in total

1.  Comparison of a commercial biochemical kit and an oligonucleotide probe for identification of environmental isolates of Vibrio vulnificus.

Authors:  A Dalsgaard; I Dalsgaard; L Høi; J L Larsen
Journal:  Lett Appl Microbiol       Date:  1996-02       Impact factor: 2.858

2.  Unusual portal of entry of Vibrio vulnificus: evidence of its prolonged survival on the skin.

Authors:  R Colodner; B Chazan; J Kopelowitz; Y Keness; R Raz
Journal:  Clin Infect Dis       Date:  2002-01-23       Impact factor: 9.079

3.  Vibrio infection in Israel due to changes in fish marketing.

Authors:  N Bisharat; R Raz
Journal:  Lancet       Date:  1996-12-07       Impact factor: 79.321

4.  Clinical, epidemiological, and microbiological features of Vibrio vulnificus biogroup 3 causing outbreaks of wound infection and bacteraemia in Israel. Israel Vibrio Study Group.

Authors:  N Bisharat; V Agmon; R Finkelstein; R Raz; G Ben-Dror; L Lerner; S Soboh; R Colodner; D N Cameron; D L Wykstra; D L Swerdlow; J J Farmer
Journal:  Lancet       Date:  1999-10-23       Impact factor: 79.321

5.  Study of genetic relationships among marine species of the genera Beneckea and Photobacterium by means of in vitro DNA/DNA hybridization.

Authors:  J L Reichelt; P Baumann; L Baumann
Journal:  Arch Microbiol       Date:  1976-10-11       Impact factor: 2.552

6.  Direct identification of Vibrio vulnificus in clinical specimens by nested PCR.

Authors:  S E Lee; S Y Kim; S J Kim; H S Kim; J H Shin; S H Choi; S S Chung; J H Rhee
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

7.  [Infection by Vibrio vulnificus after a prick from from the spine of a Tilapia].

Authors:  A Nudelman; G Edelson; A Linden; R Raz
Journal:  Harefuah       Date:  1997-11-16

8.  Phenotypic and genotypic characterization of Vibrio vulnificus: proposal for the substitution of the subspecific taxon biotype for serovar.

Authors:  E G Biosca; C Amaro; J L Larsen; K Pedersen
Journal:  Appl Environ Microbiol       Date:  1997-04       Impact factor: 4.792

9.  Use of the polymerase chain reaction in detection of culturable and nonculturable Vibrio vulnificus cells.

Authors:  L A Brauns; M C Hudson; J D Oliver
Journal:  Appl Environ Microbiol       Date:  1991-09       Impact factor: 4.792

  9 in total
  7 in total

1.  Necrotizing fasciitis from Vibrio vulnificus in a patient with undiagnosed hepatitis and cirrhosis.

Authors:  Kenneth L Muldrew; Russell R Miller; Megan Kressin; Yi-Wei Tang; Charles Stratton
Journal:  J Clin Microbiol       Date:  2007-01-24       Impact factor: 5.948

2.  Phoenix 100 versus Vitek 2 in the identification of gram-positive and gram-negative bacteria: a comprehensive meta-analysis.

Authors:  Kalliopi-Stavroula Chatzigeorgiou; Theodoros N Sergentanis; Sotirios Tsiodras; Stavros J Hamodrakas; Pantelis G Bagos
Journal:  J Clin Microbiol       Date:  2011-07-13       Impact factor: 5.948

3.  Evaluation of genotypic and phenotypic methods to distinguish clinical from environmental Vibrio vulnificus strains.

Authors:  Eva Sanjuán; Belén Fouz; James D Oliver; Carmen Amaro
Journal:  Appl Environ Microbiol       Date:  2009-01-09       Impact factor: 4.792

4.  Evaluation of the Phoenix 100 ID/AST system and NID panel for identification of Enterobacteriaceae, Vibrionaceae, and commonly isolated nonenteric gram-negative bacilli.

Authors:  Caroline M O'Hara
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

5.  Comparative genomic analysis of clinical and environmental Vibrio vulnificus isolates revealed biotype 3 evolutionary relationships.

Authors:  Yael Koton; Michal Gordon; Vered Chalifa-Caspi; Naiel Bisharat
Journal:  Front Microbiol       Date:  2015-01-15       Impact factor: 5.640

6.  Distribution of virulence markers among Vibrio vulnificus isolates of clinical and environmental origin and regional characteristics in Japan.

Authors:  Nana Yokochi; Shigemitsu Tanaka; Kouichi Matsumoto; Hirotaka Oishi; Yukihiro Tashiro; Yu Yoshikane; Mikio Nakashima; Kohzo Kanda; Genta Kobayashi
Journal:  PLoS One       Date:  2013-01-30       Impact factor: 3.240

7.  Clinical characteristics and molecular subtyping of Vibrio vulnificus illnesses, Israel.

Authors:  Ronit Zaidenstein; Chantal Sadik; Larisa Lerner; Lea Valinsky; June Kopelowitz; Ruth Yishai; Vered Agmon; Michele Parsons; Cheryl Bopp; Miriam Weinberger
Journal:  Emerg Infect Dis       Date:  2008-12       Impact factor: 6.883

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.